Minimally Invasive Surgery Symposium (MISS)
Metabolic & Endocrine Disease Summit (MEDS) Newsletter
International Congress on ATTR Amyloidosis (ICAA)
Inaugural Medscape Cardiology Newsletter
Cardiovascular and Respiratory Disease Summit (CARPS)
22nd Annual Las Vegas Dermatology Seminar
Innovations in Dermatology: Virtual Fall Conference 2021
Innovations in Dermatology Newsletter
Pain Care for Primary Care
Annual Perspectives in Rheumatic Diseases
Management of Acute Leukemia for the Community Healthcare Team
Perspectives in Breast Cancer Care
Pelvic Anatomy & Gynecologic Surgery Symposium (PAGS)
Perspectives in Malignant Hematology
Update in Non-Neoplastic Hematology
Innovations in Psychiatry Newsletter
There are no results under this Specialty.
Treat underlying factors such as obesity and diabetes to reduce risk of liver disease progression.
Lupus drugs in late-stage development seek to address unmet needs, notably in lupus nephritis.
LAS VEGAS – The agent and individual patient factors may affect the duration of treatment and the approach to resuming therapy.